VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1570722
Sex: F
Age:
State: FL

Vax Date: 03/01/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: with redness going down the side of the arm; left arm where she was injected was red and swollen; left arm where she was injected was red and swollen; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (with redness going down the side of the arm), VACCINATION SITE SWELLING (left arm where she was injected was red and swollen) and VACCINATION SITE ERYTHEMA (left arm where she was injected was red and swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced ERYTHEMA (with redness going down the side of the arm), VACCINATION SITE SWELLING (left arm where she was injected was red and swollen) and VACCINATION SITE ERYTHEMA (left arm where she was injected was red and swollen). On 23-Mar-2021, ERYTHEMA (with redness going down the side of the arm), VACCINATION SITE SWELLING (left arm where she was injected was red and swollen) and VACCINATION SITE ERYTHEMA (left arm where she was injected was red and swollen) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1570723
Sex: F
Age: 41
State: FL

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: area is a raised lump like a mosquito bite; area is hard; area is swollen; big red circle around the injection site/ red dot where the injection went into her arm; arm sore at injection site; red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (area is a raised lump like a mosquito bite), VACCINATION SITE INDURATION (area is hard), VACCINATION SITE PAIN (arm sore at injection site), VACCINATION SITE ERYTHEMA (red at injection site) and VACCINATION SITE SWELLING (area is swollen) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication. On 15-Mar-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021 at 9:00 PM, the patient experienced VACCINATION SITE PAIN (arm sore at injection site) and VACCINATION SITE ERYTHEMA (red at injection site). On 23-Mar-2021, the patient experienced VACCINATION SITE MASS (area is a raised lump like a mosquito bite), VACCINATION SITE INDURATION (area is hard), VACCINATION SITE SWELLING (area is swollen) and VACCINATION SITE ERYTHEMA (big red circle around the injection site/ red dot where the injection went into her arm). On 17-Mar-2021, VACCINATION SITE PAIN (arm sore at injection site) and VACCINATION SITE ERYTHEMA (red at injection site) had resolved. At the time of the report, VACCINATION SITE MASS (area is a raised lump like a mosquito bite), VACCINATION SITE INDURATION (area is hard), VACCINATION SITE SWELLING (area is swollen) and VACCINATION SITE ERYTHEMA (big red circle around the injection site/ red dot where the injection went into her arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: FLONASE [FLUTICASONE PROPIONATE]; BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]

Current Illness:

ID: 1570724
Sex: F
Age: 72
State: NY

Vax Date: 01/14/2021
Onset Date: 03/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea consistently everyday), DIARRHOEA (diarrhea) and CONDITION AGGRAVATED (bones continue to ache more after vax, different areas) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 013L20A) for COVID-19 vaccination. Co-suspect product included non-company product MULTIVITAMIN [VITAMINS NOS] for an unknown indication. Concurrent medical conditions included Arthritis (more pain in bones) since 1985, Hypothyroidism (underactive thyroid) since 1985, Glaucoma (MILD) since 2010, Blood pressure high (MODERATE HBP) since 1985, Drug allergy (LEVOTHYROXINE) and Drug allergy (PREMARIN). Concomitant products included DICLOFENAC SODIUM, LINUM USITATISSIMUM, MENTHOL, METHYL SALICYLATE, THIOCOLCHICOSIDE (INSTAFLEX) for Arthritis, TRAVOPROST (TRAVATAN Z) and TIMOLOL for Glaucoma, LISINOPRIL for Hypertension, NAPROXEN SODIUM (ALEVE) and ACETAMINOPHEN for Pain, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroiditis, PROBIOTICS NOS for Urinary tract disorder. On 14-Jan-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started MULTIVITAMIN [VITAMINS NOS] (Oral) 1 dosage form. On 24-Mar-2021, the patient experienced DIARRHOEA (Diarrhea consistently everyday). On 29-Jun-2021, the patient experienced DIARRHOEA (diarrhea). On an unknown date, the patient experienced CONDITION AGGRAVATED (bones continue to ache more after vax, different areas). The patient was treated with PLANTAGO OVATA (METAMUCIL [PLANTAGO OVATA]) ongoing since an unknown date for Diarrhoea, at an unspecified dose and frequency. On 29-Mar-2021, DIARRHOEA (Diarrhea consistently everyday) had resolved. At the time of the report, DIARRHOEA (diarrhea) and CONDITION AGGRAVATED (bones continue to ache more after vax, different areas) outcome was unknown. Concomitant medication included probiotic for urinary tract health and digestive health. Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15 july 2021.concomitant information updated, new event added.

Other Meds: SYNTHROID; LISINOPRIL; ALEVE; TRAVATAN Z; TIMOLOL; PROBIOTICS NOS; INSTAFLEX; ACETAMINOPHEN

Current Illness: Arthritis (more pain in bones); Blood pressure high (MODERATE HBP); Drug allergy (PREMARIN); Drug allergy (LEVOTHYROXINE); Glaucoma (MILD); Hypothyroidism (underactive thyroid)

ID: 1570725
Sex: F
Age: 70
State: FL

Vax Date: 03/10/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccination site warmth; Vaccination site pruritus; Vaccination site erythema; Itching; Vaccination site pain; Red blotches; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Red blotches), VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE PAIN (Vaccination site pain), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Penicillin allergy, Drug allergy (sulfa, keflex), Drug allergy (keflex), Hypertension, High cholesterol and Hypothyroidism. Concomitant products included METOPROLOL for Blood pressure management, EZETIMIBE and FISH OIL (OMEGA 3 FISH OILS) for Cholesterol, LEVOTHYROXINE for Thyroid disorder, CALCIUM for an unknown indication. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced RASH MACULAR (Red blotches), VACCINATION SITE PAIN (Vaccination site pain) and PRURITUS (Itching). On 12-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE ERYTHEMA (Vaccination site erythema). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Vaccination site warmth). On 28-Mar-2021, RASH MACULAR (Red blotches) and VACCINATION SITE PRURITUS (Vaccination site pruritus) had resolved. At the time of the report, VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) outcome was unknown and PRURITUS (Itching) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No treatment medication was taken. Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Additional adverse event and outcome with date of recovery for two of the events Concomitants added and 2nd dose information added, relevant history of the patient added.

Other Meds: METOPROLOL; EZETIMIBE; LEVOTHYROXINE; CALCIUM; OMEGA 3 FISH OILS

Current Illness: Drug allergy (sulfa, keflex); Drug allergy (keflex); High cholesterol; Hypertension; Hypothyroidism; Penicillin allergy

ID: 1570726
Sex: F
Age:
State: TX

Vax Date: 03/15/2021
Onset Date: 03/16/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Bruise Below the Injection site) and VACCINATION SITE RASH (Rash Below the Injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE RASH (Rash Below the Injection site). On 23-Mar-2021, the patient experienced VACCINATION SITE BRUISING (Bruise Below the Injection site). On 16-Mar-2021, VACCINATION SITE RASH (Rash Below the Injection site) had resolved. At the time of the report, VACCINATION SITE BRUISING (Bruise Below the Injection site) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Concomitant product use was not provided by the reporter. No complications after the second dose of Moderna COVID-19 vaccine. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up information received on 10-May-2021 included crosslinked case information, second dose details added and action taken updated.

Other Meds:

Current Illness:

ID: 1570727
Sex: F
Age: 71
State: NC

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: My throat got tight in the evening; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (My throat got tight in the evening) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Allergy to chemicals (Dye), Drug allergy (Codeine) and Drug allergy (steroids). On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced THROAT TIGHTNESS (My throat got tight in the evening). On 23-Feb-2021, THROAT TIGHTNESS (My throat got tight in the evening) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant product was reported The patient did not receive any treatment medication

Other Meds:

Current Illness: Allergy to chemicals (Dye); Drug allergy (steroids); Drug allergy (Codeine)

ID: 1570728
Sex: F
Age:
State: MA

Vax Date: 03/18/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Flu like symptoms; Mild reaction; Cold; Body is weak/ She does not want to go anywhere; Mild fever; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION COMPLICATION (Mild reaction), NASOPHARYNGITIS (Cold), ASTHENIA (Body is weak/ She does not want to go anywhere) and PYREXIA (Mild fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION COMPLICATION (Mild reaction), NASOPHARYNGITIS (Cold), ASTHENIA (Body is weak/ She does not want to go anywhere), PYREXIA (Mild fever) and FATIGUE (Tired). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION COMPLICATION (Mild reaction), NASOPHARYNGITIS (Cold), ASTHENIA (Body is weak/ She does not want to go anywhere), PYREXIA (Mild fever) and FATIGUE (Tired) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1570729
Sex: F
Age: 59
State: VA

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body sore/ sore arm; Stuffy Nose; Chills; headcahe; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (body sore/ sore arm), NASAL CONGESTION (Stuffy Nose), CHILLS (Chills), HEADACHE (headcahe) and PYREXIA (fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (body sore/ sore arm), NASAL CONGESTION (Stuffy Nose), CHILLS (Chills), HEADACHE (headcahe) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Fever, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (body sore/ sore arm), NASAL CONGESTION (Stuffy Nose), CHILLS (Chills), HEADACHE (headcahe) and PYREXIA (fever) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported.

Other Meds:

Current Illness:

ID: 1570730
Sex: F
Age: 61
State: NY

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: feeling sick; could not eat or drink anything; could not eat or drink anything; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (feeling sick), FEEDING DISORDER (could not eat or drink anything) and FLUID INTAKE REDUCED (could not eat or drink anything) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION COMPLICATION (feeling sick), FEEDING DISORDER (could not eat or drink anything) and FLUID INTAKE REDUCED (could not eat or drink anything). At the time of the report, VACCINATION COMPLICATION (feeling sick), FEEDING DISORDER (could not eat or drink anything) and FLUID INTAKE REDUCED (could not eat or drink anything) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. On 29-Feb-2021, the patient presented to the Emergency Room due to her symptoms. No treatment was reported for the events.

Other Meds:

Current Illness:

ID: 1570731
Sex: F
Age: 68
State: CA

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: experienced a full day of rapid heart beats; difficulty speaking; pain in back near the liver; fever that comes and goes; headaches in the mornings and evenings; weakness; diarrhea; fatigue; muscle pain; joint pain; chills; nausea; vomiting; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHENIA (weakness), DIARRHOEA (diarrhea), HEART RATE INCREASED (experienced a full day of rapid heart beats), SPEECH DISORDER (difficulty speaking) and PAIN (pain in back near the liver) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Hepatitis C. Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included UPADACITINIB (RINVOQ), PREDNISONE and CELECOXIB (CELEBREX) for an unknown indication. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced ASTHENIA (weakness), DIARRHOEA (diarrhea), FATIGUE (fatigue), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headaches in the mornings and evenings). On an unknown date, the patient experienced HEART RATE INCREASED (experienced a full day of rapid heart beats), SPEECH DISORDER (difficulty speaking), PAIN (pain in back near the liver) and PYREXIA (fever that comes and goes). At the time of the report, ASTHENIA (weakness), DIARRHOEA (diarrhea), HEART RATE INCREASED (experienced a full day of rapid heart beats), SPEECH DISORDER (difficulty speaking), PAIN (pain in back near the liver), FATIGUE (fatigue), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever that comes and goes) and HEADACHE (headaches in the mornings and evenings) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment medications were reported.

Other Meds: RINVOQ; PREDNISONE; CELEBREX

Current Illness: Rheumatoid arthritis

ID: 1570732
Sex: F
Age: 16
State: CO

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 17 years old received the Moderna COVID 19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old received the Moderna COVID 19 vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. No Medical History information was reported. On 19-Mar-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old received the Moderna COVID 19 vaccine). On 19-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old received the Moderna COVID 19 vaccine) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were reported. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Patient initials, action taken updated

Other Meds:

Current Illness:

ID: 1570733
Sex: F
Age:
State: NJ

Vax Date: 03/11/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment medication were provided. No concomitant medication were provided.

Other Meds:

Current Illness:

ID: 1570734
Sex: F
Age:
State: GA

Vax Date: 03/14/2021
Onset Date: 03/14/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm was warm; has now knots around the injection site; Arm is red; she had chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm was warm), VACCINATION SITE INDURATION (has now knots around the injection site), VACCINATION SITE ERYTHEMA (Arm is red) and CHILLS (she had chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The patient's past medical history included Knee replacement on 11-Mar-2021. Concomitant products included Pain meds for an unknown indication. On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE WARMTH (arm was warm), VACCINATION SITE INDURATION (has now knots around the injection site), VACCINATION SITE ERYTHEMA (Arm is red) and CHILLS (she had chills). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (arm was warm), VACCINATION SITE INDURATION (has now knots around the injection site), VACCINATION SITE ERYTHEMA (Arm is red) and CHILLS (she had chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient reported that her symptoms went away for a while, however on an unreported date, she picked at the scab (on her arm) and the symptoms returned.

Other Meds: Pain meds

Current Illness:

ID: 1570735
Sex: M
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rph reports that a 16 year old patient received 1st dose of vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Rph reports that a 16 year old patient received 1st dose of vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Rph reports that a 16 year old patient received 1st dose of vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Rph reports that a 16 year old patient received 1st dose of vaccine) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1570736
Sex: F
Age: 33
State: NY

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red ring at injection site site; hot and painful at injection site; tender to touch at vaccine site; hot and painful at injection site; weakness; dizziness; headache; nausea; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VACCINATION SITE WARMTH (hot and painful at injection site), ASTHENIA (weakness), VACCINATION SITE ERYTHEMA (red ring at injection site site) and VACCINATION SITE PAIN (hot and painful at injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced NAUSEA (nausea), CHILLS (chills) and PYREXIA (fever). On 21-Mar-2021, the patient experienced DIZZINESS (dizziness), ASTHENIA (weakness) and HEADACHE (headache). On an unknown date, the patient experienced VACCINATION SITE WARMTH (hot and painful at injection site), VACCINATION SITE ERYTHEMA (red ring at injection site site), VACCINATION SITE PAIN (hot and painful at injection site) and VACCINATION SITE PAIN (tender to touch at vaccine site). The patient was treated with IBUPROFEN at a dose of UNK dosage form; MULTIVITAMIN [VITAMINS NOS] at a dose of UNK dosage form and VITAMIN D NOS at a dose of UNK dosage form. At the time of the report, DIZZINESS (dizziness), VACCINATION SITE WARMTH (hot and painful at injection site), ASTHENIA (weakness), VACCINATION SITE ERYTHEMA (red ring at injection site site), VACCINATION SITE PAIN (hot and painful at injection site), VACCINATION SITE PAIN (tender to touch at vaccine site), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills) and PYREXIA (fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. This case was linked to MOD-2021-155661.

Other Meds:

Current Illness:

ID: 1570737
Sex: F
Age:
State: CA

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling on her arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling on her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swelling on her arm). At the time of the report, VACCINATION SITE SWELLING (swelling on her arm) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment was administered for the event at the time of the report.

Other Meds:

Current Illness:

ID: 1570738
Sex: F
Age: 65
State: NJ

Vax Date: 02/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccination site pain; fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain), PYREXIA (fever) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A) and 026L20A) for COVID-19 vaccination. Concurrent medical conditions included HIV infection, Allergy and Appetite disorder. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain), PYREXIA (fever) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PAIN (Vaccination site pain), PYREXIA (fever) and HEADACHE (Headache) had resolved. Concomitant medication included medications for blood pressure, HIV medicine, allergy pills, appetite pills, stomach pills. Action taken for Moderna COVID-19 Vaccine was not applicable. This case was linked to US-MODERNATX, INC.-MOD-2021-054219 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Event resolved and Patient declined FU; Sender's Comments: US-MODERNATX, INC.-MOD-2021-054219:First dose

Other Meds:

Current Illness: Allergy; Appetite disorder; HIV infection

ID: 1570739
Sex: F
Age: 71
State: CT

Vax Date: 02/14/2021
Onset Date: 02/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash all over her upper body(shoulders, chest, neck and arms); Hives; itchy and the itching is unbearable; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy and the itching is unbearable), RASH (rash all over her upper body(shoulders, chest, neck and arms)) and URTICARIA (Hives) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 031M20A) for COVID-19 vaccination. No Medical History information was reported. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced PRURITUS (itchy and the itching is unbearable). On 18-Mar-2021, the patient experienced URTICARIA (Hives). On an unknown date, the patient experienced RASH (rash all over her upper body(shoulders, chest, neck and arms)). The patient was treated with CORTISONE (topical) ongoing since an unknown date for Rash and Itch, at a dose of UNK dosage form; PEPPERMINT OIL [MENTHA X PIPERITA OIL] (topical) ongoing since an unknown date for Rash and Itch, at a dose of UNK dosage form and HYDROCORTISONE ACETATE, NEOMYCIN SULFATE (HYDROCORTISONE N) at an unspecified dose and frequency. On 23-Feb-2021, PRURITUS (itchy and the itching is unbearable) had resolved. On 19-Mar-2021, URTICARIA (Hives) had resolved. At the time of the report, RASH (rash all over her upper body(shoulders, chest, neck and arms)) had resolved. No concomitant medications were provided. The patient provided pictures of a rash which has spread over her upper body, on her shoulders, chest, neck and arms. At the time of the report, products used as treatment for the events had not provided relief of her symptoms. This case was linked to MOD-2021-027896 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 23-Mar-2021: Initial additional information received on 23 Mar 2021 contains non-significant information. On 21-May-2021: Initial additional information received on 21 May 2021 contains information regarding second dose events pics and had no previous history like this. On 31-May-2021: Initial additional information received on 31 May 2021 contains non-significant information. On 24-Jul-2021: Significant Follow-up received event and event outcome was updated

Other Meds:

Current Illness:

ID: 1570740
Sex: M
Age:
State: FL

Vax Date: 02/21/2021
Onset Date: 02/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Fever; Body aches; This spontaneous case was reported by a patient family member or friend and describes the occurrence of CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body aches) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in January 2021. Concomitant products included LOSARTAN for an unknown indication. On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Chills, Myalgia and Fever, at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), PYREXIA (Fever) and MYALGIA (Body aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: LOSARTAN

Current Illness:

ID: 1570741
Sex: F
Age: 67
State: FL

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Stomach discomfort; headache; fever; chills; Myalgia; nauseas; fatigue; Tingling lips; Eyes heavy feeling of; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (Tingling lips), ASTHENOPIA (Eyes heavy feeling of), ABDOMINAL DISCOMFORT (Stomach discomfort), HEADACHE (headache) and PYREXIA (fever) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PARAESTHESIA ORAL (Tingling lips) and ASTHENOPIA (Eyes heavy feeling of). On 23-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach discomfort), HEADACHE (headache), PYREXIA (fever), CHILLS (chills), MYALGIA (Myalgia), NAUSEA (nauseas) and FATIGUE (fatigue). On 22-Mar-2021, PARAESTHESIA ORAL (Tingling lips) and ASTHENOPIA (Eyes heavy feeling of) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (Stomach discomfort), HEADACHE (headache), PYREXIA (fever), CHILLS (chills), MYALGIA (Myalgia), NAUSEA (nauseas) and FATIGUE (fatigue) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. On 07-Feb-2021, SARS-CoV-2 antibody test: positive (Positive) Positive. On 23-Mar-2021, Body temperature: 102.6 (Inconclusive) 102.6. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The patient reported that 12 hours after the injection she experienced events headache, fever of 102.6, chills, body ache, nauseas, fatigue and sick to her stomach feeling. Concomitant product use was not provided by the reporter. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Contact Information Updated.

Other Meds:

Current Illness:

ID: 1570742
Sex: F
Age: 76
State: NH

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vertigo; chills; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo), CHILLS (chills), HEADACHE (headache) and NAUSEA (nausea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: flu shot in December 2020. Concurrent medical conditions included Vertigo (due to barometer pressure changes and weather changes.) and Feeling cold. On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced VERTIGO (vertigo), CHILLS (chills), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, VERTIGO (vertigo), CHILLS (chills), HEADACHE (headache) and NAUSEA (nausea) had not resolved. Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness: Feeling cold; Vertigo (due to barometer pressure changes and weather changes.)

ID: 1570743
Sex: F
Age: 62
State: FL

Vax Date: 03/10/2021
Onset Date: 03/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe diarrhea; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DIARRHOEA (severe diarrhea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Heart attack (has to take heart medication). On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced DIARRHOEA (severe diarrhea). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM A-D) for Diarrhea, at a dose of 1 dosage form. At the time of the report, DIARRHOEA (severe diarrhea) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. concomitant medication included heart medication

Other Meds:

Current Illness:

ID: 1570744
Sex: F
Age: 68
State: FL

Vax Date: 03/12/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 immunisation. No Medical History information was reported. On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced URTICARIA (Hives). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives) outcome was unknown. No concomitant medications reported. Action taken with mRNA-1273 in response to events was not applicable.

Other Meds:

Current Illness:

ID: 1570745
Sex: M
Age:
State: FL

Vax Date: 03/11/2021
Onset Date: 03/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itches which last 9-10 days / itchy; COVID arm / Red and itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itches which last 9-10 days / itchy) and ERYTHEMA (COVID arm / Red and itchy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced PRURITUS (itches which last 9-10 days / itchy) and ERYTHEMA (COVID arm / Red and itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itchy, at a dose of UNK dosage form. At the time of the report, PRURITUS (itches which last 9-10 days / itchy) and ERYTHEMA (COVID arm / Red and itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications included an unspecified blood pressure medication and 7 other medications that the patient didn't want to specify.

Other Meds:

Current Illness:

ID: 1570746
Sex: M
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: very cold and always hot; chills periodically; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (very cold and always hot) and CHILLS (chills periodically) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (very cold and always hot) and CHILLS (chills periodically). At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (very cold and always hot) and CHILLS (chills periodically) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1570747
Sex: F
Age: 78
State: MI

Vax Date: 03/22/2021
Onset Date: 03/23/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: had to sleep more than usual; so much pain at the injection site; very very tired - extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (had to sleep more than usual), VACCINATION SITE PAIN (so much pain at the injection site) and FATIGUE (very very tired - extremely tired) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006A21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced SOMNOLENCE (had to sleep more than usual), VACCINATION SITE PAIN (so much pain at the injection site) and FATIGUE (very very tired - extremely tired). At the time of the report, SOMNOLENCE (had to sleep more than usual), VACCINATION SITE PAIN (so much pain at the injection site) and FATIGUE (very very tired - extremely tired) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1570748
Sex: F
Age: 32
State: CA

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: First dose during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (First dose during pregnancy) in a 32-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 immunisation. No Medical History information was reported. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 22-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (First dose during pregnancy). On 22-Mar-2021, EXPOSURE DURING PREGNANCY (First dose during pregnancy) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications provided. No treatment information provided. Patient did not want to provide information about pregnancy but said patient would contact if wants to register via email.

Other Meds:

Current Illness:

ID: 1570749
Sex: F
Age: 66
State: IL

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The patient's past medical history included Surgery (Four surgeries.). Concurrent medical conditions included Hypertension, Hypothyroidism, Penicillin allergy and Allergy to antibiotic (Allergic to levaquin). Concomitant products included CARVEDILOL and LEVOTHYROXINE for an unknown indication. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore left arm). At the time of the report, PAIN IN EXTREMITY (sore left arm) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Treatment for the event was not reported. This case was linked to MOD-2021-054468 (Patient Link).

Other Meds: CARVEDILOL; LEVOTHYROXINE

Current Illness: Allergy to antibiotic (Allergic to levaquin); Hypertension; Hypothyroidism; Penicillin allergy

ID: 1570750
Sex: F
Age:
State: WI

Vax Date:
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash on torso; This spontaneous case was reported by a health care professional and describes the occurrence of RASH (Rash on torso) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced RASH (Rash on torso). The patient was treated with STEROIDS at an unspecified dose and frequency. At the time of the report, RASH (Rash on torso) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information included IV Steroids for three days. No concomitant medications reported by investigator Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow-up received including No New Information.

Other Meds:

Current Illness:

ID: 1570751
Sex: F
Age: 74
State: CA

Vax Date: 02/04/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: area is puffy and swollen; bump in the left clavicula appeared; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING (area is puffy and swollen) and MASS (bump in the left clavicula appeared) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced SWELLING (area is puffy and swollen) and MASS (bump in the left clavicula appeared). At the time of the report, SWELLING (area is puffy and swollen) and MASS (bump in the left clavicula appeared) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: result not provided (Inconclusive) The doctor didn't think it was a cist or a lymph node but made her do an ultrasound. Results received on 23-Mar-2021 but not specified. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided. No treatment was reported for the events. The patient endorsed the bump has continued to get bigger following her second dose of mRNA-1273 on 09-Mar-2021 (batch no. 036A21A).

Other Meds:

Current Illness:

ID: 1570752
Sex: F
Age: 72
State: CA

Vax Date: 02/18/2021
Onset Date: 03/18/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lots of pain when walking in the right leg; Severe joint pain right leg; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Lots of pain when walking in the right leg) and ARTHRALGIA (Severe joint pain right leg) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 004M20A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (Lots of pain when walking in the right leg) and ARTHRALGIA (Severe joint pain right leg). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 800 milligram. At the time of the report, PAIN IN EXTREMITY (Lots of pain when walking in the right leg) and ARTHRALGIA (Severe joint pain right leg) outcome was unknown. The patient indicated that the batch number for the second dose could have been either 046A21A or 096A21A, she was uncertain based on the handwriting.

Other Meds:

Current Illness:

ID: 1570753
Sex: F
Age: 70
State: CA

Vax Date: 01/27/2021
Onset Date: 03/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Second Dose Outside of Time Window; "Not feeling well"; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Dose Outside of Time Window), MALAISE ("Not feeling well") and CHILLS (Chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Dose Outside of Time Window), MALAISE ("Not feeling well") and CHILLS (Chills). On 06-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Dose Outside of Time Window) had resolved. At the time of the report, MALAISE ("Not feeling well") and CHILLS (Chills) had resolved. Treatment information was not provided. Concomitant medication were not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1570754
Sex: M
Age: 73
State: PA

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sweating from his neck to his waist only on his left side; metallic taste in his mouth when got the vaccine; felt like he was coming down with something, like he didn't feel like himself, like he had a fever.; nose was blocked like he had a severe cold; felt like he was coming down with something, like he didn't feel like himself, like he had a fever.; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), HYPERHIDROSIS (sweating from his neck to his waist only on his left side), DYSGEUSIA (metallic taste in his mouth when got the vaccine), FEELING ABNORMAL (felt like he was coming down with something, like he didn't feel like himself, like he had a fever.) and NASOPHARYNGITIS (nose was blocked like he had a severe cold) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007821A and 046821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Arthritis since 01-Jan-2002, Allergy to animal (Soft shell-clam), Penicillin allergy, Drug allergy (Tetanus anti-toxin), Contrast media allergy, Blood pressure management since 15-Dec-2018, Gout since 15-Apr-1997 and Hypercholesteraemia since 15-Dec-2018. Concomitant products included SPIRONOLACTONE from 15-Dec-2018 to an unknown date for Blood pressure management, ALLOPURINOL from 15-Apr-1997 to an unknown date for Gout, ROSUVASTATIN from 15-Dec-2018 to an unknown date for High cholesterol, METOPROLOL, ASPIRIN [ACETYLSALICYLIC ACID] from 15-Apr-1997 to an unknown date, FISH OIL, UBIDECARENONE (COQ) from 15-Apr-1997 to an unknown date, NAPROXEN SODIUM (ALEVE) and CINNAMOMUM CASSIA BARK, THIOCTIC ACID (CINNAMON ALPHA LIPOIC ACID) for an unknown indication. On 22-Mar-2021 at 1:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021 at 1:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore left arm), DYSGEUSIA (metallic taste in his mouth when got the vaccine), FEELING ABNORMAL (felt like he was coming down with something, like he didn't feel like himself, like he had a fever.), NASOPHARYNGITIS (nose was blocked like he had a severe cold) and PYREXIA (felt like he was coming down with something, like he didn't feel like himself, like he had a fever.). On 23-Mar-2021, the patient experienced HYPERHIDROSIS (sweating from his neck to his waist only on his left side). On 22-Mar-2021, NASOPHARYNGITIS (nose was blocked like he had a severe cold) had resolved. On 23-Mar-2021, DYSGEUSIA (metallic taste in his mouth when got the vaccine), FEELING ABNORMAL (felt like he was coming down with something, like he didn't feel like himself, like he had a fever.) and PYREXIA (felt like he was coming down with something, like he didn't feel like himself, like he had a fever.) had resolved. At the time of the report, PAIN IN EXTREMITY (sore left arm) had not resolved and HYPERHIDROSIS (sweating from his neck to his waist only on his left side) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No adverse events occurred after second dose. No treatment medication was not reported. Action taken with mRNA-1273 in response to the event was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Patient demographics updated, medical history information updated, dosage and route of administration for concomitant medications added, second dose of vaccine added.

Other Meds: METOPROLOL; ALLOPURINOL; SPIRONOLACTONE; ROSUVASTATIN; ASPIRIN [ACETYLSALICYLIC ACID]; FISH OIL; COQ; ALEVE; CINNAMON ALPHA LIPOIC ACID

Current Illness: Allergy to animal (Soft shell-clam); Arthritis; Blood pressure management; Contrast media allergy; Drug allergy (Tetanus anti-toxin); Gout; Hypercholesteraemia; Penicillin allergy

ID: 1570755
Sex: F
Age: 73
State: NY

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Joints ache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and ARTHRALGIA (Joints ache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced HEADACHE (Headache) and ARTHRALGIA (Joints ache). On 18-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, ARTHRALGIA (Joints ache) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Patient has taken Advil and Diclofenac Gel that was available at home

Other Meds:

Current Illness:

ID: 1570756
Sex: M
Age:
State:

Vax Date: 03/04/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore throat; couldn't sleep well; UTI; dry hacking cough; headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), INSOMNIA (couldn't sleep well), URINARY TRACT INFECTION (UTI), COUGH (dry hacking cough) and HEADACHE (headache) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A201A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat), INSOMNIA (couldn't sleep well), URINARY TRACT INFECTION (UTI), COUGH (dry hacking cough), HEADACHE (headache) and VACCINATION SITE PAIN (sore arm). At the time of the report, OROPHARYNGEAL PAIN (sore throat), INSOMNIA (couldn't sleep well), URINARY TRACT INFECTION (UTI), COUGH (dry hacking cough), HEADACHE (headache) and VACCINATION SITE PAIN (sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided. No treatment was reported for the events.

Other Meds:

Current Illness:

ID: 1570757
Sex: F
Age:
State: NY

Vax Date: 02/17/2021
Onset Date: 03/29/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Secod dose 12 days later than the original scheduled date; This spontaneous case was reported by a patient family member or friend and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Secod dose 12 days later than the original scheduled date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Secod dose 12 days later than the original scheduled date). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Secod dose 12 days later than the original scheduled date) had resolved. The patient missed their scheduled second dose (was supposed to be 17-Mar-2021) and was instead going to receive their second dose on 29-Mar-2021. Action taken with mRNA-1273 in response to the event was not applicable. No Concomitant medication were reported. No treatment medication were reported.

Other Meds:

Current Illness:

ID: 1570758
Sex: F
Age:
State: GA

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: abdominal stomach pains; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (abdominal stomach pains) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 22-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021 at 6:00 PM, the patient experienced ABDOMINAL PAIN UPPER (abdominal stomach pains). At the time of the report, ABDOMINAL PAIN UPPER (abdominal stomach pains) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. No treatment information was provided. Very limited information regarding this event/s has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

ID: 1570759
Sex: F
Age:
State:

Vax Date: 03/17/2021
Onset Date: 03/23/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sciatica and arm pain that are becoming worse and progressive; sciatica and arm pain that are becoming worse and progressive; This spontaneous case was reported by a consumer and describes the occurrence of SCIATICA (sciatica and arm pain that are becoming worse and progressive) and PAIN IN EXTREMITY (sciatica and arm pain that are becoming worse and progressive) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced SCIATICA (sciatica and arm pain that are becoming worse and progressive) and PAIN IN EXTREMITY (sciatica and arm pain that are becoming worse and progressive). At the time of the report, SCIATICA (sciatica and arm pain that are becoming worse and progressive) had not resolved and PAIN IN EXTREMITY (sciatica and arm pain that are becoming worse and progressive) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1570760
Sex: M
Age: 63
State: GA

Vax Date: 03/21/2021
Onset Date: 03/21/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Numbness in left arm/ Numbness in left side of face; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in left arm/ Numbness in left side of face) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00UB21H) for COVID-19 vaccination. Concurrent medical conditions included Diabetes and Heart disease, unspecified. On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness in left arm/ Numbness in left side of face). At the time of the report, HYPOAESTHESIA (Numbness in left arm/ Numbness in left side of face) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness: Diabetes; Heart disease, unspecified

ID: 1570761
Sex: F
Age: 60
State: TX

Vax Date: 03/11/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Eye infection after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EYE INFECTION (Eye infection after receiving the vaccine) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. Medical history was not reported. Concomitant products included ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE INFECTION (Eye infection after receiving the vaccine). The patient was treated with DOXYCYCLINE HYDROCHLORIDE (DOXICYCLINE [DOXYCYCLINE HYDROCHLORIDE]) for Eye infection, at an unspecified dose and frequency. At the time of the report, EYE INFECTION (Eye infection after receiving the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Other concomitant medication included mepathor. Reporter did not allow further contact

Other Meds: NEXIUM [ESOMEPRAZOLE SODIUM]; SYNTHROID

Current Illness:

ID: 1570762
Sex: F
Age: 67
State: FL

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: runny nose; lymph node pain in her breast; headache; feeling tired; chills; temparature of 97.3; some armpit lymph node area dicomfort/; injection site pain; body ache; little bit of dry cough; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), COUGH (little bit of dry cough), RHINORRHOEA (runny nose), LYMPHADENOPATHY (some armpit lymph node area dicomfort/) and INJECTION SITE PAIN (injection site pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included VITAMIN C [ASCORBIC ACID] and VITAMIN D [VITAMIN D NOS] for an unknown indication. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced PAIN (body ache), COUGH (little bit of dry cough), LYMPHADENOPATHY (some armpit lymph node area dicomfort/), INJECTION SITE PAIN (injection site pain), FATIGUE (feeling tired), CHILLS (chills) and PYREXIA (temparature of 97.3). On 20-Mar-2021, the patient experienced RHINORRHOEA (runny nose), LYMPH NODE PAIN (lymph node pain in her breast) and HEADACHE (headache). At the time of the report, PAIN (body ache), COUGH (little bit of dry cough), RHINORRHOEA (runny nose), LYMPHADENOPATHY (some armpit lymph node area dicomfort/), INJECTION SITE PAIN (injection site pain), LYMPH NODE PAIN (lymph node pain in her breast), FATIGUE (feeling tired), CHILLS (chills) and PYREXIA (temparature of 97.3) outcome was unknown and HEADACHE (headache) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. no treatment drugs were provided. Most recent FOLLOW-UP information incorporated above includes: On 15-May-2021: ADR Form attached- Reporter new address updated, patient height and weight given . Attached excel document with ADR form

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1570763
Sex: F
Age: 29
State: NJ

Vax Date: 07/21/2021
Onset Date: 07/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: Red dye #40 Pomegranate Kiwi Honeydew Melon

Symptom List:

Symptoms: Ongoing chest pressure, heaviness Has not gone away since it started.

Other Meds: None

Current Illness: None

ID: 1570764
Sex: F
Age: 60
State: NC

Vax Date: 07/30/2021
Onset Date: 07/31/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: no known allergies

Symptom List:

Symptoms: She shares symptoms started 5-6 hours later post date of vaccination (7/31/2021).She notes that her chest felt like a squeezing, pulling sensation. She shares her heart felt like a flutter or "flopping sensation". Pt share she was laying on her bed, then she thinks she fell asleep. When she woke up she could walk and function normally. She also admits to fatigue, weakness.

Other Meds: uknown

Current Illness: unknown

ID: 1570765
Sex: F
Age: 26
State:

Vax Date: 08/15/2021
Onset Date: 08/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: latex

Symptom List:

Symptoms: Patient was nervous before the shot. She felt fine after the shot but a few minutes later started feeling lightheaded and turned pale. Patient then lost consciousness for a few seconds and was shaking but regained consciousness. She was pale and nauseated. We gave her an ice pack and just had her remain sitting in her chair. 911 was called and we were told not to move her. The EMTs arrived within 10 minutes of the incident and took over patient's care.

Other Meds: none

Current Illness: none

ID: 1570766
Sex: M
Age: 12
State: CA

Vax Date: 08/15/2021
Onset Date: 08/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: n/a

Symptom List:

Symptoms: 2nd dose of Pfizer vaccine was given on 16th day after first dose. Informed consent questionnaire was reviewed by RPh. Pt's guardian did not indicate that any prior COVID vaccine received when asked on the form. Pharmacy will implement strategies such as reviewing form verbally with parent and checking health agency website.

Other Meds: n/a

Current Illness:

ID: 1570767
Sex: F
Age: 40
State: CA

Vax Date: 05/01/2021
Onset Date: 08/15/2021
Rec V Date: 08/15/2021
Hospital: Y

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: Eggs. Watermelon

Symptom List:

Symptoms: Hospitalization for Covid-19 on 8/15/21. Mild hypoxia, n/v at presentation- day 4 of symptoms

Other Meds: insulin, tylenol

Current Illness: n/a

ID: 1570768
Sex: F
Age: 30
State: CA

Vax Date: 08/14/2021
Onset Date: 08/15/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: No

Symptom List:

Symptoms: Under arm lymph node swelling Breast pain Lower back pain Fatigue Fever Migraines

Other Meds: Adderal

Current Illness:

ID: 1570769
Sex: F
Age: 25
State: CA

Vax Date: 08/13/2021
Onset Date: 08/13/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lightheaded and dizziness for 1 and a half day, pain in the right arm for a few days

Other Meds: Prenatal vitamins, B6, Reglan

Current Illness:

ID: 1570770
Sex: F
Age: 52
State: WI

Vax Date: 07/30/2021
Onset Date: 07/31/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies: Latex-Swelling Adhesive Tape [Tape]-Rash Nickel-Rash Peppermint Oil-Rash SeasonalRunny Nose Sulfa- DrugsItching

Symptom List:

Symptoms: Patient received care at ED on 7/21/2021: Reports she got her 2nd dose of pfizer vaccine yesterday. Had similar reaction to the first dose but back in December. Waited for second one due to first dose. Having all over weakness, HA. Also having dizziness. An 8/10 HA. Nauseated as well. Also had weird sensation over the R side of her face feeling very warm like she was on a heating pad. Symptoms started at 10pm last night. Just doesn't feel like she is getting any better. DDx considered includes but not limited to: myositis, active infxn, intra-cranial abnl. W/u for these is reassuring against emergent pathology. Most likely related to 2nd vaccine dose. Disposition: Discharge

Other Meds: acetaminophen (TYLENOL) 500 MG tablet cetirizine (ZYRTEC) 10 MG tablet fluticasone-vilanterol (BREO ELLIPTA) 200-25 MCG/INH inhaler glucosamine hcl 1000 MG tablet hydroCHLOROthiazide 25 MG tablet hydrOXYzine hcl 25 MG tablet ipratropium-alb

Current Illness: N/A

ID: 1570771
Sex: M
Age: 66
State: IL

Vax Date: 01/19/2021
Onset Date: 02/23/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling of nipples; Swelling of breast; Tenderness of breast; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NIPPLE SWELLING (Swelling of nipples), BREAST SWELLING (Swelling of breast) and BREAST TENDERNESS (Tenderness of breast) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced NIPPLE SWELLING (Swelling of nipples), BREAST SWELLING (Swelling of breast) and BREAST TENDERNESS (Tenderness of breast). At the time of the report, NIPPLE SWELLING (Swelling of nipples), BREAST SWELLING (Swelling of breast) and BREAST TENDERNESS (Tenderness of breast) had not resolved. Not Provided The patient reported taking unspecified concomitant medications. No treatment was reported for the events.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm